Placental Stem Cell Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments
- AMR-1067473
- January 2022
- Healthcare
- 154 Pages
This report is a comprehensive study that examines the Placental Stem Cell Therapy industry in depth. With reference to key regions and major nations, the study specifies the product type of Placental Stem Cell Therapy as well as its use in various industrial verticals. Furthermore, the report identified and analysed all of the top companies functioning in the global Placental Stem Cell Therapy market arena, comparing and contrasting them based on market revenue, yearly sales volume, historical growth rate, and company strategies. The worldwide Placental Stem Cell Therapy market research offers a business strategy for current market participants to strengthen their market positions based on all of these findings. Furthermore, the paper recommends a market entry strategy for newcomers to the sector.
The top vendors and distributors operating in all of the major regions have also been highlighted in the Placental Stem Cell Therapy market report. This data and research should aid market players in strengthening their market distribution networks and expanding their geographic reach.
Placental Stem Cell Therapy Market Strategic Analysis
The market was studied using several marketing methodologies such as Porter's Five Forces Analysis, player positioning analysis, SWOT analysis, market share analysis, and value chain analysis in the Placental Stem Cell Therapy market study. The market dynamics and factors such as the threat of a Placental Stem Cell Therapy substitute, the threat of new entrants into the Placental Stem Cell Therapy market, buyer bargaining power, supplier bargaining power to Placental Stem Cell Therapy providing companies, and internal rivalry among Placental Stem Cell Therapy providers are analysed in Porter's Five Forces analysis to provide the report's readers with a detailed view of the current market dynamics.
This analysis assists report users in evaluating the Placental Stem Cell Therapy market based on various parameters such as economies of scale, switching costs, brand loyalty, existing distribution channels, capital investments, manufacturing rights & patents, government regulations, advertising impact, and consumer preference impact. This simplified data is expected to aid the industry's key decision-makers in their decision-making process. Furthermore, this study answers the crucial question of whether or not new entrants should enter the Placental Stem Cell Therapy industry.
Placental Stem Cell Therapy Market Key Trends Analysis
The important factors influencing the growth of the Placental Stem Cell Therapy market have been examined in this report. The driving factors that are boosting demand for Placental Stem Cell Therapys and the restraining factors that are slowing growth of the Placental Stem Cell Therapy industry are addressed in depth, as well as their implications for the worldwide Placental Stem Cell Therapy market. In addition, the published analysis identifies and discusses in detail the trends that are driving the market and impacting its growth. In addition, other qualitative variables such as risks connected with operations and key problems faced by market players are covered in the report.
Placental Stem Cell Therapy Market Key Segment Analysis
By segmenting the market by product type, application, and geography, the study provides a clear picture of the Placental Stem Cell Therapy industry. On the basis of current and future trends, all segments of the Placental Stem Cell Therapy industry have been examined. The market and its divisions are forecasted for the years 2021 through 2028. The study identifies the categories that are contributing the most to total market revenue growth, as well as the factors that are supporting their growth.
The research will provide a detailed qualitative and quantitative product type segment analysis for the years 2021 to 2028.
The report study analyses and includes a variety of prospective prospects and aspects affecting various applications.
Placental Stem Cell Therapy Market Regional Trends and Market Player’s Analysis
North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the regions in which the market is divided. In 2020, the worldwide Placental Stem Cell Therapy market was dominated by North America. The Asia Pacific region is expected to have the highest CAGR for the Placental Stem Cell Therapy market throughout the projected period.
The market revenue, market shares, business strategies, recent developments, and growth rates of major players with substantial market shares in the global Placental Stem Cell Therapy market are all examined. These firms' recent developments, such as new solution/product launches, research projects, acquisitions, geographic expansions, and technological advancements, are taken into account when determining their position in the Placental Stem Cell Therapy market. All important stakeholders in the Placental Stem Cell Therapy value chain and technological ecosystem are expected to benefit from the insights offered in the Placental Stem Cell Therapy market research study.
In order to provide a broader understanding of the top competitors in the Placental Stem Cell Therapy market, the research includes a company market share analysis. Lifebank Stem Cell Banking, Celularity Inc., Americord Registry, ReeLabs Pvt. Ltd., Pluristem Therapeutics Inc., Mesoblast Limited, ReNeuron Group plc, Athersys Inc. are among the major participants in the global Placental Stem Cell Therapy industry.
Scope of the report
| Report Parameters | Details of Parameter |
|---|---|
| Market Size | xx Million |
| Based Year | 2021 |
| Forecast Period Covered | 2021-2028 |
| Units for value | Revenue in USD million and CAGR from 2021 to 2028 |
| Covered Segments | Component, Types, Applications, End-Users, and more. |
| Region Covered | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Companies Covered | Lifebank Stem Cell Banking, Celularity Inc., Americord Registry, ReeLabs Pvt. Ltd., Pluristem Therapeutics Inc., Mesoblast Limited, ReNeuron Group plc, Athersys Inc. |
Major Highlights of the Placental Stem Cell Therapy Market report study:
- An in-depth examination of the global Placental Stem Cell Therapy industry will be published soon.
- The study examines the global Placental Stem Cell Therapy market and offers major actionable information to its players.
- The research has taken into account all key events in the recent past, providing users with up-to-date industry information.
- The report study is expected to aid the industry's key decision-makers in their decision-making process.
- Data on market intelligence, changing market dynamics, existing and predicted market trends, and so on are included in the report.
- The research includes a detailed examination of the macroeconomic and microeconomic aspects that influence the global Placental Stem Cell Therapy industry.
- The Market Ecosystem and Adoption in Different Markets
- The global Placental Stem Cell Therapy market is being shaped by several major trends.
- The size of the Placental Stem Cell Therapy market in terms of revenue has been measured in the past and will be measured in the future in USD million.
- Consumer preference patterns and recent industrial developments
- The worldwide Placental Stem Cell Therapy market's competitive landscape and player positioning analysis
- Major players' key goods and solutions, as well as their business strategies
- Recommendations for new market entrants as well as existing market participants.
- The study of niche and potential segments (product type, application, and regions/countries) predicts that promising growth will be noticed.
- Operating players in the market encounter a number of significant hurdles.
- An examination of the major risks involved in market operations
The report segment of the global Placental Stem Cell Therapy market as follows:
Global Placental Stem Cell Therapy Market: By Product Type
- Type I
- Type II
- Type III
Global Placental Stem Cell Therapy Market: By Application
- Hematologic Malignancies and Disorders
- Congenital Immunodeficiency Disorders
- Metabolic Disorders
- Neurological Disorders
Global Placental Stem Cell Therapy Market: By Region
- North America
- U.S.
- Canada
- Rest of North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
The report study is drafted to provide actionable insights to the following mentioned audience:
- Institutes of research and consulting firms
- Companies are attempting to get into the Placental Stem Cell Therapy market.
- Universities and students
- Other companies in the Placental Stem Cell Therapy market include solution providers, product producers, service providers, and others.
- Private companies and government agencies that are linked
- Individuals interested in learning more about the Placental Stem Cell Therapy market
Manufacturers and Segments
- Lifebank Stem Cell Banking
- Celularity Inc.
- Americord Registry
- ReeLabs Pvt. Ltd.
- Pluristem Therapeutics Inc.
- Mesoblast Limited
- ReNeuron Group plc
- Athersys Inc.
- Type I
- Type II
- Type III
- Hematologic Malignancies and Disorders
- Congenital Immunodeficiency Disorders
- Metabolic Disorders
- Neurological Disorders
Have query on this report?
Make an Enquiry
1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
2. Executive Summarysegment Form
2.1. Global Placental Stem Cell Therapy Market Snapshot
2.1.1. Global Placental Stem Cell Therapy Market By Type I,2019
2.1.1.1.
2.1.1.2.Type I I
2.1.1.3.Type I II
2.1.2. Global Placental Stem Cell Therapy Market By Hematologic Malignancies and Disorders,2019
2.1.2.1.
2.1.2.2.Hematologic Malignancies and Disorders
2.1.2.3.Congenital Immunodeficiency Disorders
2.1.2.4.Metabolic Disorders
2.1.3. Global Placental Stem Cell Therapy Market By End-use,2019
2.1.4. Global Placental Stem Cell Therapy Market By Geography,2019
3. Global Placental Stem Cell Therapy Market Dynamics
3.1. Market Overview
3.2. Market Inclination Insights Analysis
3.3. Drivers
3.4. Challenges
3.5. Future Prospects
3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)
4. Global Placental Stem Cell Therapy Market Size (US$), By Type I, 2018 – 2028
4.1. Overview
4.1.1. Market Share Analysis By Type I, 2019 vs.2028
4.1.2. Attractive Investment Proposition By Type I, 2020
4.2. Global Placental Stem Cell Therapy Market Size (US$), By Type I, 2018 – 2028
5. Global Placental Stem Cell Therapy Market Size (US$), By Hematologic Malignancies and Disorders, 2018 – 2028
5.1. Overview
5.1.1. Market Share Analysis By Hematologic Malignancies and Disorders, 2019 vs.2028
5.1.2. Attractive Investment Proposition By Hematologic Malignancies and Disorders, 2020
5.2. Global Placental Stem Cell Therapy Market Size (US$), By Hematologic Malignancies and Disorders, 2018 – 2028
6. Global Placental Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028
6.1. Overview
6.1.1. Market Share Analysis By End-use, 2019 vs.2028
6.1.2. Attractive Investment Proposition By End-use, 2020
6.2. Global Placental Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028
7. Global Placental Stem Cell Therapy Market Size (US$), By Geography, 2018 – 2028
7.1. Overview
7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
7.1.2. Attractive Investment Proposition by Geography, 2020
7.2. North America Placental Stem Cell Therapy Market Analysis, 2018 – 2028
7.2.1. North America Placental Stem Cell Therapy Market Size (US$), By Country, 2018 – 2028
7.2.1.1. U.S.
7.2.1.2. Canada
7.2.2. North America Placental Stem Cell Therapy Market Size (US$), By Type I, 2018 – 2028
7.2.3. North America Placental Stem Cell Therapy Market Size (US$), By Hematologic Malignancies and Disorders, 2018 – 2028
7.2.4. North America Placental Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028
7.3. Europe Placental Stem Cell Therapy Market Analysis, 2018 – 2028
7.3.1. Europe Placental Stem Cell Therapy Market Size (US$), By Country, 2018 – 2028
7.3.1.1. U.K.
7.3.1.2. Germany
7.3.1.3. France
7.3.1.4. Rest of Europe
7.3.2. Europe Placental Stem Cell Therapy Market Size (US$), By Type I, 2018 – 2028
7.3.3. Europe Placental Stem Cell Therapy Market Size (US$), By Hematologic Malignancies and Disorders, 2018 – 2028
7.3.4. Europe Placental Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028
7.4. Asia Pacific Placental Stem Cell Therapy Market Analysis , 2018 – 2028
7.4.1. Asia Pacific Placental Stem Cell Therapy Market Size (US$), By Country, 2018 – 2028
7.4.1.1. China
7.4.1.2. Japan
7.4.1.3. India
7.4.1.4. Rest of Asia Pacific
7.4.2. Asia Pacific Placental Stem Cell Therapy Market Size (US$), By Type I, 2018 – 2028
7.4.3. Asia Pacific Placental Stem Cell Therapy Market Size (US$), By Hematologic Malignancies and Disorders, 2018 – 2028
7.4.4. Asia Pacific Placental Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028
7.5. Latin America Placental Stem Cell Therapy Market Analysis, 2018 – 2028
7.5.1. Latin America Placental Stem Cell Therapy Market Size (US$), By Country, 2018 – 2028
7.5.1.1. Brazil
7.5.1.2. Mexico
7.5.1.3. Rest of Latin America
7.5.2. Latin America Placental Stem Cell Therapy Market Size (US$), By Type I, 2018 – 2028
7.5.3. Latin America Placental Stem Cell Therapy Market Size (US$), By Hematologic Malignancies and Disorders, 2018 – 2028
7.5.4. Latin America Placental Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028
7.6. Middle East & Africa (MEA) Placental Stem Cell Therapy Market Analysis, 2018 – 2028
7.6.1. MEA Placental Stem Cell Therapy Market Size (US$), By Region, 2018 – 2028
7.6.1.1. GCC Countries
7.6.1.2. South Africa
7.6.1.3. Rest of MEA
7.6.2. MEA Placental Stem Cell Therapy Market Size (US$), By Type I, 2018 – 2028
7.6.3. MEA Placental Stem Cell Therapy Market Size (US$), By Hematologic Malignancies and Disorders, 2018 – 2028
7.6.4. MEA Placental Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028
8. Company Profiles
8.1. Competitive Analysis
8.2. Market Positioning of Key Vendors
8.3. Key Strategies adopted by the Leading Players
8.4. Key Placental Stem Cell Therapy Providers
8.4.1 Lifebank Stem Cell Banking
8.4.1.1 Business Description
8.4.1.2 Lifebank Stem Cell Banking Geographic Operations
8.4.1.3 Lifebank Stem Cell Banking Financial Information
8.4.1.4 Lifebank Stem Cell Banking Product Positions/Portfolio
8.4.1.5 Lifebank Stem Cell Banking Key Developments
8.4.2 Celularity Inc.
8.4.2.1 Business Description
8.4.2.2 Celularity Inc. Geographic Operations
8.4.2.3 Celularity Inc. Financial Information
8.4.2.4 Celularity Inc. Product Positions/Portfolio
8.4.2.5 Celularity Inc. Key Developments
8.4.3 Americord Registry
8.4.3.1 Business Description
8.4.3.2 Americord Registry Geographic Operations
8.4.3.3 Americord Registry Financial Information
8.4.3.4 Americord Registry Product Positions/Portfolio
8.4.3.5 Americord Registry Key Developments
8.4.4 ReeLabs Pvt. Ltd.
8.4.4.1 Business Description
8.4.4.2 ReeLabs Pvt. Ltd. Geographic Operations
8.4.4.3 ReeLabs Pvt. Ltd. Financial Information
8.4.4.4 ReeLabs Pvt. Ltd. Product Positions/Portfolio
8.4.4.5 ReeLabs Pvt. Ltd. Key Developments
8.4.5 Pluristem Therapeutics Inc.
8.4.5.1 Business Description
8.4.5.2 Pluristem Therapeutics Inc. Geographic Operations
8.4.5.3 Pluristem Therapeutics Inc. Financial Information
8.4.5.4 Pluristem Therapeutics Inc. Product Positions/Portfolio
8.4.5.5 Pluristem Therapeutics Inc. Key Developments
8.4.6 Mesoblast Limited
8.4.6.1 Business Description
8.4.6.2 Mesoblast Limited Geographic Operations
8.4.6.3 Mesoblast Limited Financial Information
8.4.6.4 Mesoblast Limited Product Positions/Portfolio
8.4.6.5 Mesoblast Limited Key Developments
8.4.7 ReNeuron Group plc
8.4.7.1 Business Description
8.4.7.2 ReNeuron Group plc Geographic Operations
8.4.7.3 ReNeuron Group plc Financial Information
8.4.7.4 ReNeuron Group plc Product Positions/Portfolio
8.4.7.5 ReNeuron Group plc Key Developments
8.4.8 Athersys Inc.
8.4.8.1 Business Description
8.4.8.2 Athersys Inc. Geographic Operations
8.4.8.3 Athersys Inc. Financial Information
8.4.8.4 Athersys Inc. Product Positions/Portfolio
8.4.8.5 Athersys Inc. Key Developments
LIST OF TABLES
TABLE 1 Market Snapshot: Global Placental Stem Cell Therapy Market
TABLE 2 Impact Indicators
TABLE 3 Impact Analysis of Drivers and Restraints
TABLE 4 North America Placental Stem Cell Therapy Market Revenue, By Type I, 2018 – 2028 (US$ Mn)
TABLE 5 North America Placental Stem Cell Therapy Market Revenue, By Hematologic Malignancies and Disorders, 2018 – 2028 (US$ Mn)
TABLE 6 North America Placental Stem Cell Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 7 Europe Placental Stem Cell Therapy Market Revenue, By Type I, 2018 – 2028 (US$ Mn)
TABLE 8 Europe Placental Stem Cell Therapy Market Revenue, By Hematologic Malignancies and Disorders, 2018 – 2028 (US$ Mn)
TABLE 9 Europe Placental Stem Cell Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 10 Asia Pacific Placental Stem Cell Therapy Market Revenue, By Type I, 2018 – 2028 (US$ Mn)
TABLE 11 Asia Pacific Placental Stem Cell Therapy Market Revenue, By Hematologic Malignancies and Disorders, 2018 – 2028 (US$ Mn)
TABLE 12 Asia Pacific Placental Stem Cell Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 13 Latin America Placental Stem Cell Therapy Market Revenue, By Type I, 2018 – 2028 (US$ Mn)
TABLE 14 Latin America Placental Stem Cell Therapy Market Revenue, By Hematologic Malignancies and Disorders, 2018 – 2028 (US$ Mn)
TABLE 15 Latin America Placental Stem Cell Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Placental Stem Cell Therapy Market Revenue, By Type I, 2018 – 2028 (US$ Mn)
TABLE 17 MEA Placental Stem Cell Therapy Market Revenue, By Hematologic Malignancies and Disorders, 2018 – 2028 (US$ Mn)
TABLE 18 MEA Placental Stem Cell Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
LIST OF FIGURES
FIG. 1 Global Placental Stem Cell Therapy: Market Segmentation
FIG. 2 Global Placental Stem Cell Therapy Market: Research Methodology
FIG. 3 Top-Down and Bottom-up Approach
FIG. 4 Global Placental Stem Cell Therapy Market, By Type I, 2019 (US$ Mn)
FIG. 5 Global Placental Stem Cell Therapy Market, By Hematologic Malignancies and Disorders, 2019 (US$ Mn)
FIG. 6 Global Placental Stem Cell Therapy Market, By End-use, 2019 (US$ Mn)
FIG. 7 Global Placental Stem Cell Therapy Market, By Geography, 2019 (US$ Mn)
FIG. 8 Global Placental Stem Cell Therapy Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition
FIG. 10 Market Positioning of Key Placental Stem Cell Therapy Providers, 2019
FIG. 11 Global Placental Stem Cell Therapy Market Revenue Contribution, By Type I, 2019 & 2028 (Value %)
FIG. 12 Global Placental Stem Cell Therapy Market Revenue Contribution, By Hematologic Malignancies and Disorders, 2019 & 2028 (Value %)
FIG. 13 Global Placental Stem Cell Therapy Market Revenue Contribution, By End-use, 2019 & 2028 (Value %)
FIG. 14 North America Placental Stem Cell Therapy Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 15 Europe Placental Stem Cell Therapy Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 16 Asia Pacific Placental Stem Cell Therapy Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 17 Latin America Placental Stem Cell Therapy Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Placental Stem Cell Therapy Market Revenue, 2018 – 2028, (US$ Mn)
Key Takeaways:
1. Market value and estimate of the Placental Stem Cell Therapy market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
2. Executive Summarysegment Form
2.1. Global Placental Stem Cell Therapy Market Snapshot
2.1.1. Global Placental Stem Cell Therapy Market By Type I,2019
2.1.1.1.
2.1.1.2.Type I I
2.1.1.3.Type I II
2.1.2. Global Placental Stem Cell Therapy Market By Hematologic Malignancies and Disorders,2019
2.1.2.1.
2.1.2.2.Hematologic Malignancies and Disorders
2.1.2.3.Congenital Immunodeficiency Disorders
2.1.2.4.Metabolic Disorders
2.1.3. Global Placental Stem Cell Therapy Market By End-use,2019
2.1.4. Global Placental Stem Cell Therapy Market By Geography,2019
3. Global Placental Stem Cell Therapy Market Dynamics
3.1. Market Overview
3.2. Market Inclination Insights Analysis
3.3. Drivers
3.4. Challenges
3.5. Future Prospects
3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)
4. Global Placental Stem Cell Therapy Market Size (US$), By Type I, 2018 – 2028
4.1. Overview
4.1.1. Market Share Analysis By Type I, 2019 vs.2028
4.1.2. Attractive Investment Proposition By Type I, 2020
4.2. Global Placental Stem Cell Therapy Market Size (US$), By Type I, 2018 – 2028
5. Global Placental Stem Cell Therapy Market Size (US$), By Hematologic Malignancies and Disorders, 2018 – 2028
5.1. Overview
5.1.1. Market Share Analysis By Hematologic Malignancies and Disorders, 2019 vs.2028
5.1.2. Attractive Investment Proposition By Hematologic Malignancies and Disorders, 2020
5.2. Global Placental Stem Cell Therapy Market Size (US$), By Hematologic Malignancies and Disorders, 2018 – 2028
6. Global Placental Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028
6.1. Overview
6.1.1. Market Share Analysis By End-use, 2019 vs.2028
6.1.2. Attractive Investment Proposition By End-use, 2020
6.2. Global Placental Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028
7. Global Placental Stem Cell Therapy Market Size (US$), By Geography, 2018 – 2028
7.1. Overview
7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
7.1.2. Attractive Investment Proposition by Geography, 2020
7.2. North America Placental Stem Cell Therapy Market Analysis, 2018 – 2028
7.2.1. North America Placental Stem Cell Therapy Market Size (US$), By Country, 2018 – 2028
7.2.1.1. U.S.
7.2.1.2. Canada
7.2.2. North America Placental Stem Cell Therapy Market Size (US$), By Type I, 2018 – 2028
7.2.3. North America Placental Stem Cell Therapy Market Size (US$), By Hematologic Malignancies and Disorders, 2018 – 2028
7.2.4. North America Placental Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028
7.3. Europe Placental Stem Cell Therapy Market Analysis, 2018 – 2028
7.3.1. Europe Placental Stem Cell Therapy Market Size (US$), By Country, 2018 – 2028
7.3.1.1. U.K.
7.3.1.2. Germany
7.3.1.3. France
7.3.1.4. Rest of Europe
7.3.2. Europe Placental Stem Cell Therapy Market Size (US$), By Type I, 2018 – 2028
7.3.3. Europe Placental Stem Cell Therapy Market Size (US$), By Hematologic Malignancies and Disorders, 2018 – 2028
7.3.4. Europe Placental Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028
7.4. Asia Pacific Placental Stem Cell Therapy Market Analysis , 2018 – 2028
7.4.1. Asia Pacific Placental Stem Cell Therapy Market Size (US$), By Country, 2018 – 2028
7.4.1.1. China
7.4.1.2. Japan
7.4.1.3. India
7.4.1.4. Rest of Asia Pacific
7.4.2. Asia Pacific Placental Stem Cell Therapy Market Size (US$), By Type I, 2018 – 2028
7.4.3. Asia Pacific Placental Stem Cell Therapy Market Size (US$), By Hematologic Malignancies and Disorders, 2018 – 2028
7.4.4. Asia Pacific Placental Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028
7.5. Latin America Placental Stem Cell Therapy Market Analysis, 2018 – 2028
7.5.1. Latin America Placental Stem Cell Therapy Market Size (US$), By Country, 2018 – 2028
7.5.1.1. Brazil
7.5.1.2. Mexico
7.5.1.3. Rest of Latin America
7.5.2. Latin America Placental Stem Cell Therapy Market Size (US$), By Type I, 2018 – 2028
7.5.3. Latin America Placental Stem Cell Therapy Market Size (US$), By Hematologic Malignancies and Disorders, 2018 – 2028
7.5.4. Latin America Placental Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028
7.6. Middle East & Africa (MEA) Placental Stem Cell Therapy Market Analysis, 2018 – 2028
7.6.1. MEA Placental Stem Cell Therapy Market Size (US$), By Region, 2018 – 2028
7.6.1.1. GCC Countries
7.6.1.2. South Africa
7.6.1.3. Rest of MEA
7.6.2. MEA Placental Stem Cell Therapy Market Size (US$), By Type I, 2018 – 2028
7.6.3. MEA Placental Stem Cell Therapy Market Size (US$), By Hematologic Malignancies and Disorders, 2018 – 2028
7.6.4. MEA Placental Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028
8. Company Profiles
8.1. Competitive Analysis
8.2. Market Positioning of Key Vendors
8.3. Key Strategies adopted by the Leading Players
8.4. Key Placental Stem Cell Therapy Providers
8.4.1 Lifebank Stem Cell Banking
8.4.1.1 Business Description
8.4.1.2 Lifebank Stem Cell Banking Geographic Operations
8.4.1.3 Lifebank Stem Cell Banking Financial Information
8.4.1.4 Lifebank Stem Cell Banking Product Positions/Portfolio
8.4.1.5 Lifebank Stem Cell Banking Key Developments
8.4.2 Celularity Inc.
8.4.2.1 Business Description
8.4.2.2 Celularity Inc. Geographic Operations
8.4.2.3 Celularity Inc. Financial Information
8.4.2.4 Celularity Inc. Product Positions/Portfolio
8.4.2.5 Celularity Inc. Key Developments
8.4.3 Americord Registry
8.4.3.1 Business Description
8.4.3.2 Americord Registry Geographic Operations
8.4.3.3 Americord Registry Financial Information
8.4.3.4 Americord Registry Product Positions/Portfolio
8.4.3.5 Americord Registry Key Developments
8.4.4 ReeLabs Pvt. Ltd.
8.4.4.1 Business Description
8.4.4.2 ReeLabs Pvt. Ltd. Geographic Operations
8.4.4.3 ReeLabs Pvt. Ltd. Financial Information
8.4.4.4 ReeLabs Pvt. Ltd. Product Positions/Portfolio
8.4.4.5 ReeLabs Pvt. Ltd. Key Developments
8.4.5 Pluristem Therapeutics Inc.
8.4.5.1 Business Description
8.4.5.2 Pluristem Therapeutics Inc. Geographic Operations
8.4.5.3 Pluristem Therapeutics Inc. Financial Information
8.4.5.4 Pluristem Therapeutics Inc. Product Positions/Portfolio
8.4.5.5 Pluristem Therapeutics Inc. Key Developments
8.4.6 Mesoblast Limited
8.4.6.1 Business Description
8.4.6.2 Mesoblast Limited Geographic Operations
8.4.6.3 Mesoblast Limited Financial Information
8.4.6.4 Mesoblast Limited Product Positions/Portfolio
8.4.6.5 Mesoblast Limited Key Developments
8.4.7 ReNeuron Group plc
8.4.7.1 Business Description
8.4.7.2 ReNeuron Group plc Geographic Operations
8.4.7.3 ReNeuron Group plc Financial Information
8.4.7.4 ReNeuron Group plc Product Positions/Portfolio
8.4.7.5 ReNeuron Group plc Key Developments
8.4.8 Athersys Inc.
8.4.8.1 Business Description
8.4.8.2 Athersys Inc. Geographic Operations
8.4.8.3 Athersys Inc. Financial Information
8.4.8.4 Athersys Inc. Product Positions/Portfolio
8.4.8.5 Athersys Inc. Key Developments
LIST OF TABLES
TABLE 1 Market Snapshot: Global Placental Stem Cell Therapy Market
TABLE 2 Impact Indicators
TABLE 3 Impact Analysis of Drivers and Restraints
TABLE 4 North America Placental Stem Cell Therapy Market Revenue, By Type I, 2018 – 2028 (US$ Mn)
TABLE 5 North America Placental Stem Cell Therapy Market Revenue, By Hematologic Malignancies and Disorders, 2018 – 2028 (US$ Mn)
TABLE 6 North America Placental Stem Cell Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 7 Europe Placental Stem Cell Therapy Market Revenue, By Type I, 2018 – 2028 (US$ Mn)
TABLE 8 Europe Placental Stem Cell Therapy Market Revenue, By Hematologic Malignancies and Disorders, 2018 – 2028 (US$ Mn)
TABLE 9 Europe Placental Stem Cell Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 10 Asia Pacific Placental Stem Cell Therapy Market Revenue, By Type I, 2018 – 2028 (US$ Mn)
TABLE 11 Asia Pacific Placental Stem Cell Therapy Market Revenue, By Hematologic Malignancies and Disorders, 2018 – 2028 (US$ Mn)
TABLE 12 Asia Pacific Placental Stem Cell Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 13 Latin America Placental Stem Cell Therapy Market Revenue, By Type I, 2018 – 2028 (US$ Mn)
TABLE 14 Latin America Placental Stem Cell Therapy Market Revenue, By Hematologic Malignancies and Disorders, 2018 – 2028 (US$ Mn)
TABLE 15 Latin America Placental Stem Cell Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Placental Stem Cell Therapy Market Revenue, By Type I, 2018 – 2028 (US$ Mn)
TABLE 17 MEA Placental Stem Cell Therapy Market Revenue, By Hematologic Malignancies and Disorders, 2018 – 2028 (US$ Mn)
TABLE 18 MEA Placental Stem Cell Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
LIST OF FIGURES
FIG. 1 Global Placental Stem Cell Therapy: Market Segmentation
FIG. 2 Global Placental Stem Cell Therapy Market: Research Methodology
FIG. 3 Top-Down and Bottom-up Approach
FIG. 4 Global Placental Stem Cell Therapy Market, By Type I, 2019 (US$ Mn)
FIG. 5 Global Placental Stem Cell Therapy Market, By Hematologic Malignancies and Disorders, 2019 (US$ Mn)
FIG. 6 Global Placental Stem Cell Therapy Market, By End-use, 2019 (US$ Mn)
FIG. 7 Global Placental Stem Cell Therapy Market, By Geography, 2019 (US$ Mn)
FIG. 8 Global Placental Stem Cell Therapy Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition
FIG. 10 Market Positioning of Key Placental Stem Cell Therapy Providers, 2019
FIG. 11 Global Placental Stem Cell Therapy Market Revenue Contribution, By Type I, 2019 & 2028 (Value %)
FIG. 12 Global Placental Stem Cell Therapy Market Revenue Contribution, By Hematologic Malignancies and Disorders, 2019 & 2028 (Value %)
FIG. 13 Global Placental Stem Cell Therapy Market Revenue Contribution, By End-use, 2019 & 2028 (Value %)
FIG. 14 North America Placental Stem Cell Therapy Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 15 Europe Placental Stem Cell Therapy Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 16 Asia Pacific Placental Stem Cell Therapy Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 17 Latin America Placental Stem Cell Therapy Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Placental Stem Cell Therapy Market Revenue, 2018 – 2028, (US$ Mn)
Key Takeaways:
1. Market value and estimate of the Placental Stem Cell Therapy market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage
List of Tables
TABLE Market Snapshot: Global Placental Stem Cell Therapy MarketTABLE Impact Pointers
TABLE Impact Analysis of Drivers and Restraints
TABLE North America Placental Stem Cell Therapy Market Value, By Segment1, 2018 – 2028
TABLE North America Placental Stem Cell Therapy Market Value, By Segment2, 2018 – 2028
TABLE North America Placental Stem Cell Therapy Market Value, By Country, 2018 – 2028
TABLE Europe Placental Stem Cell Therapy Market Value, By Segment1, 2018 – 2028
TABLE Europe Placental Stem Cell Therapy Market Value, By Segment2, 2018 – 2028
TABLE Europe Placental Stem Cell Therapy Market Value, By Country, 2018 – 2028
TABLE Asia Pacific Placental Stem Cell Therapy Market Value, By Segment1, 2018 – 2028
TABLE Asia Pacific Placental Stem Cell Therapy Market Value, By Segment2, 2018 – 2028
TABLE Asia Pacific Placental Stem Cell Therapy Market Value, By Country, 2018 – 2028
TABLE Latin America Placental Stem Cell Therapy Market Value, By Segment1, 2018 – 2028
TABLE Latin America Placental Stem Cell Therapy Market Value, By Segment2, 2018 – 2028
TABLE Latin America Placental Stem Cell Therapy Market Value, By Country, 2018 – 2028
TABLE MEA Placental Stem Cell Therapy Market Value, By Segment1, 2018 – 2028
TABLE MEA Placental Stem Cell Therapy Market Value, By Segment2, 2018 – 2028
TABLE MEA Placental Stem Cell Therapy Market Value, By Country, 2018 – 2028
TABLE Lifebank Stem Cell Banking: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE Celularity Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE Americord Registry: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE ReeLabs Pvt. Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE Pluristem Therapeutics Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE Mesoblast Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE ReNeuron Group plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE Athersys Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
List of Figures
FIG. Global Placental Stem Cell Therapy Market: Research MethodologyFIG. Top-Down and Bottom Up Approach
FIG. Global Placental Stem Cell Therapy Market, By Segment1, 2019 (US$ Mn)
FIG. Global Placental Stem Cell Therapy Market, By Segment2, 2019 (US$ Mn)
FIG. Global Placental Stem Cell Therapy Market, By Geography, 2019 (US$ Mn)
FIG. Global Placental Stem Cell Therapy Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. Attractive Investment Proposition
FIG. Market Positioning of Key Placental Stem Cell Therapy Providers, 2016
FIG. Global Placental Stem Cell Therapy Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG. Global Type I Market Value, 2018 – 2028, (US$ Mn)
FIG. Global Type II Market Value, 2018 – 2028, (US$ Mn)
FIG. Global Type III Market Value, 2018 – 2028, (US$ Mn)
FIG. Global Placental Stem Cell Therapy Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG. Global Hematologic Malignancies and Disorders Market Value, 2018 – 2028, (US$ Mn)
FIG. Global Congenital Immunodeficiency Disorders Market Value, 2018 – 2028, (US$ Mn)
FIG. Global Metabolic Disorders Market Value, 2018 – 2028, (US$ Mn)
FIG. Global Neurological Disorders Market Value, 2018 – 2028, (US$ Mn)
FIG. U.S. Placental Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG. Canada Placental Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG. UK Placental Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG. Germany Placental Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG. France Placental Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG. Rest of Europe Placental Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG. China Placental Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG. Japan Placental Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG. India Placental Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG. Rest of Asia Pacific Placental Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG. Mexico Placental Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG. Brazil Placental Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG. Rest of Latin America Placental Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG. GCC Countries Placental Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG. South Africa Placental Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG. Rest of MEA Placental Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)